Analyzed at DCCC (A&P Program)
Analyzed by Researcher (PUF Program)
Analyzed at DCCC (A&P Program)
Requestor | Project Title |
---|---|
Jennifer Conway | Early Improvement in Clinical Status Impacts VAD Survival in Children |
Kathleen E. Simpson | Right Heart Failure in Children After Initial Lvad Implantation Within the Pedimacs Registry Experience |
Sharon Chen | Outcomes after First Infection in Adolescents and Young Adults with Ventricular Assist Devices: An Analysis of the PEDIMACS-INTERMACS Database |
James Kirklin | Quantifying the Devastation From Stroke During Support With Continuous Flow Pumps: An Intermacs Analysis |
José Tallaj | The Impact of VAD Clinical Course on Post-Transplant Survival: A Merged Intermacs and OPTN Data Project |
Jeffrey Teuteberg | Outcomes in Late Right Heart Failure after LVAD: A Contemporary Analysis of the New Intermacs 4.0 Definition |
J. Eduardo Rame | The Ebb and Flow of Right Heart Failure in INTERMACS: Does Right Heart Failure Get Better or Worse Over Time |
Ryan Cantor | Trends in Pediatric Mechanical Circulatory Support: Are Patients, Devices, and Outcomes Changing |
Seth Hollander | Failure to Improve Renal Function Following VAD Placement Predicts Renal Injury and Chronic Kidney Disease Following Cardiac Transplant |
Scott Auerbach | The Effect of Infectious Complications During Ventricular Assist Device Use on Outcomes of Pediatric Heart Transplantation |
Stavros Drakos | Late-onset Right Heart Failure Following LVAD Implantation: Definitions, Epidemiology, Risk Factors and Outcomes |
Douglas Franz | Trajectories in Long-Term Kidney Function Post-MCSD Implant |
Valluvan Jeevanandam | Using INTERMACS to Define and Develop Performance Criteria for the “Less Sick” CHF Populaiton |
Renzo Y.Loyaga-Rendon | ECMO as Bridge to LVAD-an Analysis of INTERMACS Data |
Syed Peer | Comparison Durable Ventricular Assist Device (VAD) Implantation with and without Extracorporeal Membrane Oxygenation (ECMO) Therapy as Bridge |
Analyzed by Researcher (PUF Program)
Requestor | Project Title |
---|---|
Suzanne Arnold | Predictors of Health Status Improvement after DT-LVAD |
Maya Guglin | Cardiac Power for Prediction of Outcomes in Patients with LVADs |
Maya Guglin | Right Atrial Pressure is the Best Hemodynamic Predictor of Mortality among LVAD recipients |
Farooq Sheikh | MCS Outcomes in Patients with Inflammatory Cardiomyopathies |
Jennifer Cowger | Correlation of Blood Pressure on LVAD Support with Outcomes: An Analysis of INTERMACS Data |
Simon Maltais | Validation and Development of a Hemocompatibility Scoring System for Patients Implanted with Approved CF-LVAD |
Andrew Xanthopoulos | Differences in Thrombotic Events Based on Sildenafil Use between Low Level Hemolysis LVAD Patients |
Robert Kormos | Characterizing Patterns and Relationships Between Adverse Events: Timing and Clustering of Events associated with LVADs within the INTERMACS/Medicare Cohort |
Arene Butto | Severity of Illness at the Time of MCS implantation in Children (Pedimacs) |
Ryan Butts | Utilization and Outcomes for BiVADs in Pedimacs Patients (Pedimacs) |